On Track to Profitability, Price Target Increased (MST), page-159

Here is the post solely about the conference, if this is removed then the platform is completely unusable.


Several conferences are happening at the moment for Nova Eye Medical, including the ESCRS (which I will post
more about when it is over - but it is BIG) and one in China. The China one is especially interesting to me, with a comment about exciting things coming from this market within the next 12 months, and also the new iTrack Advance being showcased and taught to doctors (hinting at an approval in the very near term). This is a market I have often been quite excited about in my posts, as Nova Eye Medical has just one of only two approved devices in this market, plus iTrack Advance is the only MIGS device with evidence supporting use in closed angle cases (which is the most common cause of Glaucoma in Asia + the riskiest form).

Quite exciting though, China FDA approval for iTrack Advance is likely one of many near term price sensitive catalysts that the market isn't even thinking about.